CVS Health Co. (NYSE:CVS) Shares Sold by Athena Investment Management

Athena Investment Management decreased its holdings in shares of CVS Health Co. (NYSE:CVS) by 6.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 6,193 shares of the pharmacy operator’s stock after selling 428 shares during the period. Athena Investment Management’s holdings in CVS Health were worth $278,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in CVS. Proffitt & Goodson Inc. increased its stake in CVS Health by 10.6% during the 4th quarter. Proffitt & Goodson Inc. now owns 11,321 shares of the pharmacy operator’s stock worth $508,000 after buying an additional 1,084 shares during the period. Richard W. Paul & Associates LLC increased its stake in CVS Health by 8.6% during the 4th quarter. Richard W. Paul & Associates LLC now owns 16,527 shares of the pharmacy operator’s stock worth $742,000 after buying an additional 1,305 shares during the period. Metis Global Partners LLC increased its stake in CVS Health by 5.4% during the 4th quarter. Metis Global Partners LLC now owns 42,211 shares of the pharmacy operator’s stock worth $1,895,000 after buying an additional 2,147 shares during the period. Providence First Trust Co purchased a new stake in CVS Health during the 4th quarter worth $42,000. Finally, Fisher Asset Management LLC increased its stake in CVS Health by 10.9% during the 4th quarter. Fisher Asset Management LLC now owns 81,561 shares of the pharmacy operator’s stock worth $3,661,000 after buying an additional 8,004 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the topic of several analyst reports. UBS Group dropped their price target on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 11th. Piper Sandler dropped their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. Wolfe Research boosted their target price on shares of CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 11th. Evercore ISI boosted their target price on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Monday, January 27th. Finally, TD Cowen boosted their target price on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $69.83.

CVS Health Trading Up 2.1 %

Shares of CVS stock opened at $65.85 on Friday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75. The stock has a fifty day moving average of $54.33 and a two-hundred day moving average of $56.46. The firm has a market capitalization of $83.02 billion, a PE ratio of 17.99, a price-to-earnings-growth ratio of 0.98 and a beta of 0.61.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, research analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.04%. CVS Health’s dividend payout ratio (DPR) is 72.68%.

Insider Activity

In related news, Director Michael F. Mahoney bought 30,000 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were bought at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the transaction, the director now directly owns 39,356 shares of the company’s stock, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.24% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.